Antitope to Present at 2008 AAPS National Biotechnology Conference, Toronto, Canada; June 26 2008

Dr. Matthew Baker, CSO of Antitope, will be presenting a paper entitled ‘Immunological Background' in the session ‘Unwanted Immunogenicity of Protein Therapeutics' at this year's AAPS National Biotechnology Conference in Toronto. Dr. Baker will be presenting in a session covering many of the predictive, clinical and regulatory challenges of addressing immunogenicity in protein therapeutics.

The paper will introduce the session, giving a comprehensive overview of the mechanisms of immunological responses to protein therapeutics including the respective roles of T and B lymphocytes in recognising self- and non-self antigens, as well as outlining methods for predicting and addressing unwanted immunogenicity.

For more information, visit the conference website at http://www.aapspharmaceutica.com/meetings/biotec/bt08/index.asp